IMMUCOR INC
10-Q, EX-27, 2000-10-16
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUCOR INC, 10-Q, 2000-10-16
Next: MEDI DATA INTERNATIONAL INC, 10QSB, 2000-10-16



<TABLE> <S> <C>

<ARTICLE>                                          5


<S>                                                  <C>
<PERIOD-TYPE>                                      3-MOS
<FISCAL-YEAR-END>                                  MAY-31-2001
<PERIOD-END>                                       AUG-31-2000
<CASH>                                                                                  2835238
<SECURITIES>                                                                                  0
<RECEIVABLES>                                                                          22144030
<ALLOWANCES>                                                                                  0
<INVENTORY>                                                                            18039030
<CURRENT-ASSETS>                                                                       47180154
<PP&E>                                                                                 25193887
<DEPRECIATION>                                                                          8268808
<TOTAL-ASSETS>                                                                        104091202
<CURRENT-LIABILITIES>                                                                  23729652
<BONDS>                                                                                38242164
                                                                         0
                                                                                   0
<COMMON>                                                                                 727762
<OTHER-SE>                                                                             37735850
<TOTAL-LIABILITY-AND-EQUITY>                                                          104091612
<SALES>                                                                                17081242
<TOTAL-REVENUES>                                                                       17081242
<CGS>                                                                                   8567954
<TOTAL-COSTS>                                                                           8567954
<OTHER-EXPENSES>                                                                        7936090
<LOSS-PROVISION>                                                                              0
<INTEREST-EXPENSE>                                                                       865715
<INCOME-PRETAX>                                                                         (199429)
<INCOME-TAX>                                                                              16002
<INCOME-CONTINUING>                                                                     (215431)
<DISCONTINUED>                                                                                0
<EXTRAORDINARY>                                                                               0
<CHANGES>                                                                                     0
<NET-INCOME>                                                                            (215431)
<EPS-BASIC>                                                                               (0.03)
<EPS-DILUTED>                                                                             (0.03)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission